US5348730A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for preparing medicinal aerosol formulation containing coated medicament
Assignee: 3M Co
•
Filing: 1990-09-20
•
Granted: 1994-09-20
•
Expires: 2010-09-20
Abstract
Abstract A method for preparing a self-propelling, powder dispersing aerosol composition comprising at least 0.0001% by weight of a finely-divided solid medicament coated with a non-perfluorinated surface active dispersing agent which constitutes at least 0.0001% by weight of the coated solid material, and suspended in an aerosol propellant in which the non-perfluorinated surface-active dispersing agent is substantially insoluble. Propellant-insoluble non-perfluorinated surfactants are used to prepare stable dispersions of powdered medicament by way of pre-coating the medicament with the surfactant prior to admixture with propellant.
Inventors
- 👤 David J. Greenleaf
- 👤 Tarlochan S. Purewal
- 👤 Philip A. Jinks
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 21:31
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/007; A61K9/0073; A61K9/008; A61K9/48; A61K9/50; A61K9/5005; A61K9/5015
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
113 words
A method for preparing an aerosol composition comprising: a) coating a finely divided solid drug with non-perfluorinated surface-active dispersing agent in a solvent in which the finely divided solid drug is substantially insoluble to afford a coated solid medicament, (b) separating the coated solid medicament from the solvent, (c) drying the coated solid medicament, (d) dispersing the coated solid medicament in an aerosol propellant substantially free of chlorofluorocarbons and in which the surface active dispersing agent is substantially insoluble such that the aerosol composition comprises from 0,001% to 20% by weight of said coated solid medicament and 0,001% to 50% by weight of the coated solid medicament is the non-perfluorinated surface-active dispersing agent.
Claim 2
Independent Claim
113 words
A method for preparing an aerosol composition comprising: a) coating a finely divided solid drug with non-perfluorinated surface-active dispersing agent in a solvent in which the finely divided solid drug is substantially insoluble to afford a coated solid medicament, (b) separating the coated solid medicament from the solvent, (c) drying the coated solid medicament, (d) dispersing the coated solid medicament in an aerosol propellant substantially free of chlorofluorocarbons and in which the surface active dispersing agent is substantially insoluble such that the aerosol composition comprises from 0,001% to 20% by weight of said coated solid medicament and 0,001% to 50% by weight of the coated solid medicament is the non-perfluorinated surface-active dispersing agent.
Claim 3
Dependent Claim
26 words
A method according to claim 1, wherein the finely-divided solid medicament of step (a) has an average particle size of less than 10 microns in diameter.
Claim 4
Dependent Claim
97 words
A method according to claim 1, wherein the dispersing agent of step (a) is selected from the group consisting of sorbitan trioleate, sorbitan mono-oleate, sorbitan monolaurate, polyoxyethylene (20) sorbitan monolaurate, polyoxyethylene (20) sorbitan mono-oleate, natural lecithin, oleyl polyoxyethylene (2) ether, stearyl polyoxyethylene (2) ether, lauryl polyoxyethylene (4) ether, block copolymers of oxyethylene and oxypropylene, Oleic acid, Synthetic lecithin, Diethylene glycol dioleate, Tetrahydrofurfuryl oleate, Ethyl oleate, Isopropyl myristate, Glyceryl mono-oleate, Glyceryl monostearate, Glyceryl monoricinoleate, Cetyl alcohol, Stearyl alcohol, Polyethylene glycol 400 and Cetyl pyridinium chloride, olive oil, glyceryl monolaurate, corn oil, cotton seed oil and sunflower seed oil.
Claim 5
Dependent Claim
53 words
A method according to claim 1, wherein the finely divided solid medicament of step (a) comprises a drug selected from the group consisting of an antiallergic, an analgesic, a bronchodilator, an antihistamine, a steroid, an antitussive, an anginal preparation, an antibiotic, an antiinflammatory, a hormone, a sulfonamide, and a therapeutic protein or peptide.
Claim 6
Dependent Claim
33 words
A method according to claim 4, wherein the drug is selected from the group consisting of salbutamol and its salts, beclomethasone dipropionate, pirbuterol and its salts, adrenaline and its salts, and disodium cromoglycate.
Claim 7
Dependent Claim
14 words
A method according to claim 1, wherein the propellant of step (d) comprises 1,1,1,2-tetrafluoroethane.
Claim 8
Dependent Claim
31 words
A method according to claim 6, wherein the propellant of step (d) further comprises an adjuvant selected from the group consisting of perfluoropropane, perfluorobutane, octafluorocyclobutane, perfluoropentane, perfluorohexane, perfluorotributylamine, perfluoromethylcyclohexane and perfluorodecalin.
Claim 9
Dependent Claim
30 words
A method according to claim 7, wherein the propellant of step (d) comprises from 5 to 50% by weight of adjuvant and from 50 to 95% by weight of 1,1,1,2-tetrafluoroethane.
References Cited (Backward Citations)
GB837465A
Cited
US3014844A
Cited
GB1063512A
Cited
GB977934A
Cited
DE1719443A1
Cited
US4174295A
Cited
GB2001334A
Cited
US4352789A
Cited
US4520142A
Cited
US5141674A
Cited
US4849427A
Cited
EP0372777B1
Cited
WO1990007333A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-09-19 | 1998-03-21 | 1998-09-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-09-19 | 2002-03-21 | 2002-09-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-09-19 | 2006-03-21 | 2006-09-20 | $7700.00 | Window Closed / Lapsed |